Found 336 articles for: "eczema"
ARTICLE: Clinical Insights About the Role of pH in Atopic Dermatitis
December 2019 | Volume 18 | Issue 12 | Supplement Individual Articles | 215 | Copyright © December 2019
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a prevalence of up to 25% of children and ranging from 2.1% to 4.9% of adults worldwide.1 AD has tripled since the ...
Read MoreDupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis
October 2019 | Volume 18 | Issue 10 | Features | 1053 | Copyright © October 2019
Dupilumab inhibits the interleukin-4 receptor subunit α and is FDA approved for treatment of moderate-to-severe atopic dermatitis. It is a relatively new drug, and whether it is efficacious for ...
Read MoreEfficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis
October 2019 | Volume 18 | Issue 10 | Original Article | 1038 | Copyright © October 2019
Objective: The study was conducted to determine the efficacy of the botanical combination incorporated in Kamedis Eczema Therapy Cream (the test product) for children with mild to mod...
Read MoreA Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old
October 2019 | Volume 18 | Issue 10 | Original Article | 1020 | Copyright © October 2019
Introduction: Atopic dermatitis (AD) is a chronic, relapsing skin disease starting typically in atopic-prone children between 3&nd...
Read MorePrescribing Patterns for Atopic Dermatitis in the United States
October 2019 | Volume 18 | Issue 10 | Original Article | 987 | Copyright © October 2019
Introduction: Although future atopic dermatitis (AD) clinical research is intended to improve standard-of-care treatment, how patients are currently treated is not well characterized....
Read MoreIntralesional Steroids for the Management of Periorificial Granulomatous Dermatitis
September 2019 | Volume 18 | Issue 9 | Features | 955 | Copyright © September 2019
A42-year-old male with skin type I and a history of rosacea and eczema presented with crusting, erythema, and pustules distributed on the left oral commissure. Angular cheilitis was diagnosed and regu...
Read MoreHalobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy
August 2019 | Volume 18 | Issue 8 | Original Article | 815 | Copyright © August 2019
Background: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Topical corticosteroids (TCS) are the mainstay of treatment. Long-term safet...
Read MoreEfficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
August 2019 | Volume 18 | Issue 8 | Original Article | 804 | Copyright © August 2019
Dupilumab, a monoclonal antibody that blocks the shared receptor subunit for interleukin (IL)-4 and IL-13, is currently approved for the treatment of adults with inadequately controlled moderate-to-se...
Read MoreTwo Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis
August 2019 | Volume 18 | Issue 8 | Original Article | 790 | Copyright © August 2019
Background: A novel foam formulation of halobetasol propionate, 0.05% (HBP-Foam) has been developed to treat plaque psoriasis in patients who prefer a thermostable topical foam with l...
Read MoreConnecting the Dots: From Skin Barrier Dysfunction to Allergic Sensitization, and the Role of Moisturizers in Repairing the Skin Barrier
June 2019 | Volume 18 | Issue 6 | Original Article | 581 | Copyright © June 2019
The skin is one of the largest immunologic organs in the body and a continuous target for allergic and immunologic responses. Impairment of the skin barrier increases the likelihood of external antige...
Read MoreValidation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
June 2019 | Volume 18 | Issue 6 | Original Article | 557 | Copyright © June 2019
Objective: The study was conducted to determine the efficiency of the botanicals combination incorporated in the Kamedis Eczema Therapy Cream (the tested product) for adults and child...
Read MoreCosmetic Laser Procedures in Latin Skin
March 2019 | Volume 18 | Issue 3 | Supplement Individual Articles | 127 | Copyright © March 2019
Hispanics/Latinos are one of the fastest growing segments in the skin of color population in the United States. Utilization of lasers especially in people with skin of color requires a thorough unders...
Read MoreTopical Treatment for the Management of Atopic Dermatitis
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 112 | Copyright © February 2019
Atopic dermatitis affects up to 20% of children and continues to increase in prevalence. Effective disease control is aimed at decreasing symptoms and reducing the frequency of flares, which may be co...
Read MoreManagement of Atopic Dermatitis
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 111 | Copyright © February 2019
Atopic Dermatitis (AD) is estimated to affect 15-20% of children and remains a major health consideration for pediatricians and dermatologists.1 Over the past three decades, studies have shown an incr...
Read MoreThe Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 100 | Copyright © February 2019
Topical delivery of therapeutic agents for skin diseases is a major advantage in dermatology. However, the efficacy and tolerability of topically applied therapies is dependent on several characterist...
Read MoreVehicles Always Matter
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 99 | Copyright © February 2019
It has been said that the best treatment for a given patient is the one that the patient will actually use. The comment, often spoken with humor, actually underscores several important aspects of derm...
Read MoreA Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab
February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019
A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years tha...
Read MoreApplications of Topical Oak Bark Extract in Dermatology: Clinical Examples and Discussion
February 2019 | Volume 18 | Issue 2 | Original Article | 203 | Copyright © February 2019
The versatility of wound healing and anti-inflammatory agents can be assets to dermatologists when other therapies lack appropriate mechanisms of action, or when the risk to benefit ratio may be in qu...
Read MoreA Review of the Dermatologic Symptoms of Idiopathic Mast Cell Activation Syndrome
February 2019 | Volume 18 | Issue 2 | Original Article | 162 | Copyright © February 2019
Since the first reported cases in 2007, idiopathic mast cell activation syndrome has been increasingly recognized. Understanding of the cutaneous manifestations of this condition is imperative for der...
Read MoreSystemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
February 2019 | Volume 18 | Issue 2 | Original Article | 122 | Copyright © February 2019
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects around 13% of children and 7% of adults in the US. It can have a significant impact on the quality of life (QoL) of affected ...
Read More